Compare Stocks → Obama’s Forever Term [exposed] (From Porter & Company) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:APYXNASDAQ:HSAQNASDAQ:ICCMNYSE:ISR Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPYXApyx Medical$1.60+4.6%$1.48$1.21▼$7.97$55.42M1.1137,052 shs76,789 shsHSAQHealth Sciences Acquisitions Co. 2$5.21+12.8%$5.00$9.41▼$13.80$58.42M0.09205,918 shs36,645 shsICCMIceCure Medical$1.04+2.0%$1.22$0.52▼$1.57$47.45M0.7578,756 shs136,687 shsISRIsoray$0.37$0.19▼$0.45$54.57M1.48290,697 shs145,000 shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPYXApyx Medical+8.51%-7.83%+10.07%-34.05%-74.24%HSAQHealth Sciences Acquisitions Co. 20.00%-2.83%+3.22%-31.09%-71.62%ICCMIceCure Medical-15.00%-12.82%-21.54%-25.55%-19.69%ISRIsoray0.00%0.00%0.00%0.00%0.00%Bill Clinton Backing Biden Replacement??? (Ad)Bill Clinton is back. And he just met in Mexico with the one person I believe could REPLACE Joe Biden by August…Click here now for my urgent election forecast.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAPYXApyx Medical4.0168 of 5 stars3.53.00.04.21.71.70.6HSAQHealth Sciences Acquisitions Co. 2N/AN/AN/AN/AN/AN/AN/AN/AICCMIceCure Medical2.6147 of 5 stars3.55.00.00.02.70.00.6ISRIsorayN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAPYXApyx Medical3.00Buy$6.17285.42% UpsideHSAQHealth Sciences Acquisitions Co. 2N/AN/AN/AN/AICCMIceCure Medical3.00Buy$2.95183.65% UpsideISRIsorayN/AN/AN/AN/ACurrent Analyst RatingsLatest ISR, ICCM, APYX, and HSAQ Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/16/2024ICCMIceCure MedicalHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$3.004/4/2024ICCMIceCure MedicalHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$3.003/20/2024ICCMIceCure MedicalAlliance Global PartnersSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$1.90 ➝ $2.903/20/2024ICCMIceCure MedicalHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$3.003/5/2024ICCMIceCure MedicalHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$3.00(Data available from 5/17/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAPYXApyx Medical$52.35M1.06N/AN/A$0.59 per share2.71HSAQHealth Sciences Acquisitions Co. 2N/AN/AN/AN/A($0.62) per shareN/AICCMIceCure Medical$3.23M14.69N/AN/A$0.27 per share3.85ISRIsoray$10.80M0.00N/AN/A$0.43 per share0.00Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAPYXApyx Medical-$18.71M-$0.66N/AN/AN/A-45.20%-76.16%-32.98%8/8/2024 (Estimated)HSAQHealth Sciences Acquisitions Co. 2-$380KN/A0.00∞N/AN/AN/A-2.38%N/AICCMIceCure Medical-$14.65M-$0.33N/AN/AN/A-453.76%-86.96%-68.63%5/27/2024 (Estimated)ISRIsoray-$7.27M-$0.07N/AN/AN/A-115.91%-17.12%-16.15%N/ALatest ISR, ICCM, APYX, and HSAQ EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/9/2024Q1 2024APYXApyx Medical-$0.18-$0.22-$0.04-$0.22$9.64 million$10.24 million 4/3/2024Q4 2023ICCMIceCure Medical-$0.08-$0.07+$0.01-$0.07N/A$1.26 million 3/21/2024Q4 2023APYXApyx Medical-$0.13-$0.19-$0.06-$0.10$14.40 million$14.66 millionDividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAPYXApyx MedicalN/AN/AN/AN/AN/AHSAQHealth Sciences Acquisitions Co. 2N/AN/AN/AN/AN/AICCMIceCure MedicalN/AN/AN/AN/AN/AISRIsorayN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAPYXApyx Medical1.645.874.94HSAQHealth Sciences Acquisitions Co. 2N/A0.170.61ICCMIceCure Medical0.033.663.08ISRIsorayN/A14.3813.99OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAPYXApyx Medical55.33%HSAQHealth Sciences Acquisitions Co. 289.71%ICCMIceCure Medical0.62%ISRIsoray11.32%Insider OwnershipCompanyInsider OwnershipAPYXApyx Medical13.10%HSAQHealth Sciences Acquisitions Co. 221.90%ICCMIceCure Medical2.44%ISRIsoray2.42%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableAPYXApyx Medical25234.64 million30.11 millionOptionableHSAQHealth Sciences Acquisitions Co. 2411.21 million8.76 millionNot OptionableICCMIceCure Medical7145.62 million44.51 millionNot OptionableISRIsorayN/A142.11 million138.67 millionNot OptionableISR, ICCM, APYX, and HSAQ HeadlinesRecent News About These CompaniesMay 11, 2024 | bc.eduIn Memoriam: Patricia DohertyNovember 22, 2023 | morningstar.comFrench ISR Label Revamp ReportMay 13, 2023 | news.google.comUnexpected growth of Radiation Therapy Market in future with Top Companies Data, In-depth Analysis, Business I - openPRMay 13, 2023 | news.google.comMedical Brachytherapy Device Market: Is Thriving With Rising Latest ... - StreetBuzzMay 12, 2023 | news.google.comRadiotherapy Devices Market Size To See Huge Growth By 2031 ... - Taiwan NewsMay 11, 2023 | news.google.comRadiotherapy Machines Market by Revenue, Growth, Demand and ... - Cottonwood Holladay JournalMay 11, 2023 | news.google.comRadiotherapy Market Opportunities, Development Status and ... - Cottonwood Holladay JournalMay 11, 2023 | news.google.comRadiation Oncology Market Opportunities, Development Status and ... - Cottonwood Holladay JournalMay 11, 2023 | news.google.comSuperficial Radiation Therapy System Market is expected to reach ... - Future Market InsightsMay 10, 2023 | news.google.comRadiation Therapy Market Size, Share, Industry, Forecast to 2030 - openPRMay 10, 2023 | news.google.comBrachytherapy Market Economic Aspect with Industry Capacity ... - Cottonwood Holladay JournalMay 10, 2023 | news.google.comBrachytherapy Market Stand Out As The Biggest Contributor To ... - Digital JournalMay 10, 2023 | news.google.comRadiotherapy Devices Market Analysis, Overview, Trends, Key ... - Cottonwood Holladay JournalMay 9, 2023 | news.google.comGlobal Intraoperative Radiation Therapy Market Size, Analysis ... - Cottonwood Holladay JournalMay 9, 2023 | news.google.comRadiation Therapy Market to Reach US$ 10.6 bn by 2031, Product ... - Digital JournalMay 9, 2023 | news.google.comPhilippines Radiotherapy Market Future Business Opportunities ... - Digital JournalMay 9, 2023 | news.google.comGlobal Radiotherapy Market 2023 Outlook By Product, Application ... - Cottonwood Holladay JournalMay 8, 2023 | news.google.comGlobal Teletherapy Machines Market Research Report 2023 by ... - The Northwestern ExaminerMay 8, 2023 | news.google.comGlobal Pituitary Cancer Market Key Leaders Analysis, Segmentation ... - The Northwestern ExaminerMay 7, 2023 | news.google.comGlobal Tumor Radiation Therapy Market 2022 to 2031 Analysis ... - FylladeyNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop Headlines3 Stocks Leading the U.S. Agriculture ComebackApril 26, 2024 10:10 AMView 3 Stocks Leading the U.S. Agriculture ComebackHow to Use Put Debit Spreads to Profit From Falling Stocks April 26, 2024 9:30 AMView How to Use Put Debit Spreads to Profit From Falling Stocks Stock market today: Alphabet and Microsoft help Wall Street clinch its best week in nearly 6 monthsApril 26, 2024 3:21 AMView Stock market today: Alphabet and Microsoft help Wall Street clinch its best week in nearly 6 monthsSeagate Technology Warns Cloud Demand is Heating Up April 30, 2024 10:10 AMView Seagate Technology Warns Cloud Demand is Heating Up Intuitive Surgical Leads the Robotic Surgery MovementApril 22, 2024 6:10 AMView Intuitive Surgical Leads the Robotic Surgery MovementAll HeadlinesCompany DescriptionsApyx MedicalNASDAQ:APYXApyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets in the United States and internationally. It operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). The company offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. Its Helium Plasma Technology products are marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. It also develops and manufactures hand pieces for open and laparoscopic procedures; and OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.Health Sciences Acquisitions Co. 2NASDAQ:HSAQHealth Sciences Acquisitions Corporation 2 does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more businesses in the biopharma and medical technology sectors in North America or Europe. Health Sciences Acquisitions Corporation 2 was incorporated in 2020 and is based in New York, New York.IceCure MedicalNASDAQ:ICCMIceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a single probe system for the treatment of breast tumors; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.IsorayNYSE:ISRIsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.